Effect of Tacrolimus vs Intravenous Cyclophosphamide on Complete or Partial Response in Patients With Lupus Nephritis
Sign Up to like & getrecommendations! Published in 2022 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2022.4492
Abstract: Key Points Question What is the efficacy and safety of tacrolimus vs intravenous cyclophosphamide (IVCY) as initial therapy for lupus nephritis (LN) among Chinese patients? Findings In this randomized clinical trial of 299 patients, the… read more here.
Keywords: tacrolimus intravenous; lupus nephritis; complete partial; tacrolimus ... See more keywords
Intravenous Cyclophosphamide Therapy for Anti-IFN-γ Autoantibody-Associated Talaromyces marneffei Infection
Sign Up to like & getrecommendations! Published in 2022 at "Open Forum Infectious Diseases"
DOI: 10.1093/ofid/ofac612
Abstract: Abstract High titers of anti-interferon-γ autoantibodies (AIGAs) are an important factor leading to persistent, relapsed, and refractory infections in HIV-negative hosts infected with Talaromyces marneffei (TM). We report 5 patients treated with pulses of high-dose… read more here.
Keywords: aiga titers; ivcy therapy; therapy; talaromyces marneffei ... See more keywords
Therapeutic efficacy of combined glucocorticoid, intravenous cyclophosphamide, and double-filtration plasmapheresis for skin sclerosis in diffuse systemic sclerosis
Sign Up to like & getrecommendations! Published in 2020 at "Medicine"
DOI: 10.1097/md.0000000000019301
Abstract: Abstract We treated skin sclerosis with triple therapy consisting of a glucocorticoid, intravenous cyclophosphamide, and double-filtration plasmapheresis. The objective of this study was to analyze its effectiveness in a case series of patients who received… read more here.
Keywords: intravenous cyclophosphamide; glucocorticoid intravenous; sclerosis; skin sclerosis ... See more keywords
Efficacy of corticosteroid and intravenous cyclophosphamide in acute exacerbation of idiopathic pulmonary fibrosis: A propensity score‐matched analysis
Sign Up to like & getrecommendations! Published in 2019 at "Respirology"
DOI: 10.1111/resp.13506
Abstract: Acute exacerbation (AE) is a leading cause of death in patients with idiopathic pulmonary fibrosis (IPF). Although optimal treatment for AE‐IPF remains unclear, high‐dose corticosteroids (CS) with/without immunosuppressants, including intravenous cyclophosphamide (IVCY), are often used… read more here.
Keywords: idiopathic pulmonary; intravenous cyclophosphamide; pulmonary fibrosis; acute exacerbation ... See more keywords